Presently, studies with hens are ongoing in which animals are being monitored prospectively with IL-16-targeted contrast agents together with serum IL-16 levels to detect spontaneous ovarian tumor development at relatively earlier stages. Here, IL16 is linked to ovarian neoplasm.